Life Technologies Acquires LSK, Leading Instruments Distributor in Korea

   Life Technologies Acquires LSK, Leading Instruments Distributor in Korea

Acquisition further strengthens company's go-direct strategy in South Korea

PR Newswire

CARLSBAD, Calif., June 13, 2013

CARLSBAD, Calif., June 13, 2013 /PRNewswire/ --Life Technologies Corporation
(NASDAQ: LIFE) today announced the acquisition of Life Science Korea (LSK), a
leading instrument distributor based in Seoul, South Korea. LSK has been Life
Technologies' primary instrument distributor since 1994 and holds distribution
rights to Applied Biosystems® products, including next-generation sequencing
instruments, Sanger sequencing systems, forensics and PCR products.

"The acquisition of LSK is in line with our go-direct strategy in South Korea
and builds on our current capabilities and platforms in this important
market," said Mark Smedley, president of Life Technologies, Asia Pacific Japan
region. "The combination of Life Technologies Korea and LSK – bolstered by our
recent acquisition of consumables distributor KDR – enables us to offer one
channel to serve the many different needs of our South Korean customers and to
create a superior purchasing experience."

In addition to driving a superior customer experience, the combination of LSK
and Life Technologies will help continue to build a strong Life Technologies
brand in Korea to stimulate fast and sustainable growth and be well positioned
to take advantage of Korea's focus on developing biotechnology. In the past
five years, South Korea has shown solid growth in the biotechnology industry
and with the Korean government's Bio-vision 2016 initiative, it's expected the
country will continue to heavily invest in the life sciences industry.

LSK serves more than 1,000 customers in academia, government, pharmaceutical,
biotech, hospitals and applied markets. Under the acquisition terms,
theLSKname will become part of Life Technologies Korea. No other terms of
the deal were announced.

About Life Technologies
Life Technologies Corporation(NASDAQ:LIFE) is a global biotechnology company
that is committed to providing the most innovative products and services to
leading customers in the fields of scientific research, genetic analysis and
applied sciences. With a presence in more than 180 countries, the company's
portfolio of 50,000 end-to-end solutions is secured by more than 5,000 patents
and licenses that span the entire biological spectrum -- scientific
exploration, molecular diagnostics, 21^stcentury forensics, regenerative
medicine and agricultural research. Life Technologies has approximately 10,000
employees and had sales of $3.8 billion in 2012.

Life Technologies' Safe Harbor Statement
This press release includes forward-looking statements about our anticipated
results that involve risks and uncertainties. Some of the information
contained in this press release, including, but not limited to, statements as
to industry trends and Life Technologies' plans, objectives, expectations and
strategy for its business, contains forward-looking statements that are
subject to risks and uncertainties that could cause actual results or events
to differ materially from those expressed or implied by such forward-looking
statements. Any statements that are not statements of historical fact are
forward-looking statements. When used, the words "believe," "plan," "intend,"
"anticipate," "target," "estimate," "expect" and the like, and/or future tense
or conditional constructions ("will," "may," "could," "should," etc.), or
similar expressions, identify certain of these forward-looking statements.
Important factors which could cause actual results to differ materially from
those in the forward-looking statements are detailed in filings made byLife
Technologies with the Securities and Exchange Commission.Life Technologies
undertakes no obligation to update or revise any such forward-looking
statements to reflect subsequent events or circumstances.

(Logo: http://photos.prnewswire.com/prnh/20110216/MM49339LOGO)

Media Contact:
Suzanne Hatcher
suzanne.hatcher@lifetech.com
+1 760-268-7912

Investor Relations Contact:
Agnes Lee
agnes.lee@lifetech.com
+1 760-268-7971

SOURCE Life Technologies Corporation

Website: http://www.lifetechnologies.com